CD14 and rheumatoid arthritis: However, in relation to control group, RA patients with low disease activity exhibited an increased number and percentage of intermediate (CD14++CD16+) monocytes, whereas patients with high disease activity exhibited an increased absolute monocyte number and an increased number of classical (CD14++CD16−) and intermediate (CD14++CD16+) monocytes.